Biliverdin IXβ Reductase
Developing first-in-class therapy for patients with thrombocytopenia. Background: Thrombocytopenia is a medical condition characterized by low platelet counts. Thrombocytopenia can be brought on as a result of a separate disorder such as leukemia, an immune system problem or it can be an adverse result of taking medication, such as chemotherapy. Symptoms...
Published: 11/22/2023
|
Inventor(s): Wadie Bahou, Song Wu
Keywords(s): Technologies
Category(s): Campus > Stony Brook University, Technology Classifications > Therapeutics
|